Karl Heath

Merck & Co., Inc., Rahway, NJ, USA (United States)

1

h-index

1

Publications

1,684

Citations

Publications

1 shown

Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial

Tanguy Y. Seiwert , Barbara Burtness , Ranee Mehra +9 more

2016 The Lancet Oncology 1684 citations

Frequent Co-Authors

Tanguy Y. Seiwert

University of Chicago

Barbara Burtness

Yale Cancer Center

Ranee Mehra

Fox Chase Cancer Center

Jared Weiss

UNC Lineberger Comprehensive Cancer Center

Raanan Berger

Sheba Medical Center

Joseph P. Eder

Yale University

Researcher Info

h-index: 1
Publications: 1
Citations: 1,684
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)

External Links

Google Scholar

Impact Metrics

h-index 1

h-index: Number of publications with at least h citations each.